SG-ADVISER

SG-ADVISER mtDNA provides comprehensive analysis of mitochondrial DNA (mtDNA) variants from next-generation sequencing (NGS) data by leveraging MToolBox-derived algorithms for assembly, heteroplasmy estimation, haplogroup assignment, variant annotation, and prioritization to support studies of mitochondrial genetics, aging, and disease.


Key Features:

  • Mitochondrial genome assembly: Assembles mitochondrial genomes from NGS data using MToolBox-derived methods.
  • Heteroplasmy quantification: Determines heteroplasmic fractions for mtDNA variants.
  • Haplogroup assignment: Assigns mitochondrial haplogroups to samples.
  • Variant annotation and prioritization: Provides functional annotation and prioritization analyses of mitochondrial variants.
  • Data integration with MToolBox: Integrates and enables comparison of mtDNA annotations obtained via the MToolBox platform.
  • Validation with cohort data: Tested on unpublished data from a cohort of 200 healthy aging individuals (Erikson et al., Cell, 2016) with reported observations on heteroplasmic variants in older populations.

Scientific Applications:

  • Mitochondrial genetics: Analysis of mtDNA variation and its genetic context from NGS experiments.
  • Aging research: Investigation of heteroplasmy dynamics and age-related changes in mitochondrial DNA.
  • Disease studies: Support for research into sudden death and rare genetic disorders involving mtDNA variants.

Methodology:

Integrates MToolBox algorithms to perform mitochondrial genome assembly, heteroplasmy assessment, haplogroup determination, variant calling, annotation, and functional impact prediction from NGS data.

Topics

Details

Tool Type:
web application
Added:
8/11/2018
Last Updated:
11/25/2024

Operations

Publications

Rueda M, Torkamani A. SG-ADVISER mtDNA: a web server for mitochondrial DNA annotation with data from 200 samples of a healthy aging cohort. BMC Bioinformatics. 2017;18(1). doi:10.1186/s12859-017-1778-6. PMID:28821228. PMCID:PMC5563004.

PMID: 28821228
PMCID: PMC5563004
Funding: - National Institutes of Health: 5 UL1 RR025774, U01 HG006476

Documentation